BlackRock, Inc. 13D and 13G filings for Core Laboratories N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-29 12:13 pm Sale | 2025-03-31 | 13G | Core Laboratories N.V. CLB | BlackRock Inc. BLK | 7,261,751 15.500% | -716,524 (-8.98%) | Filing |
| 2024-01-22 2:03 pm Purchase | 2023-12-31 | 13G | Core Laboratories N.V. CLB | BlackRock Inc. BLK | 7,978,275 17.100% | 2,286,499 (+40.17%) | Filing |
| 2023-06-08 1:25 pm Purchase | 2023-05-31 | 13G | Core Laboratories N.V. CLB | BlackRock Inc. BLK | 5,691,776 12.200% | 5,691,776 (New Position) | Filing |